[**The Future of Ultrasound**](/content/post/the-future-of-ultrasound/index.html) Ultrasound represents one of the most dramatic advancements in modern day medical diagnostics. With roughly 60 million ultrasound scans performed in the US annually, its importance is obvious and technological advances have been significant and consistent. From the introduction of grey scale B-mode imaging in the early 70s, to Doppler 3D/4D scans, ultrasound now represents an invaluable tool in obstetrics, cardiology, emergency medicine and beyond. --- [**Interview with a Cardiologist with Expertise in Echocardiography**](/content/post/interview-with-a-cardiologist-with-expertise-in-echocardiography/index.html) We recently spoke with a leading cardiologist specializing in echocardiography and hypertrophic cardiomyopathy (HCM), whose clinical work focuses on caring for adults with this complex genetic heart condition and whose research focuses on advancing risk prediction and early diagnosis through advanced imaging and computational analysis. --- [**Ultrasound’s Next Leap: The Importance of Transducer Innovation**](/content/post/ultrasound-s-next-leap-the-importance-of-transducer-innovation/index.html) Ultrasound remains one of the most widely used imaging modalities in medicine. It’s real-time, radiation-free, and comparatively cost-effective. Yet as clinical expectations rise, innovation pressure across the entire ultrasound stack, from software to sensors, has been squeezed as well. --- [**Interview with Dr. Sanjiv Bhalla, MD, CCFP-EM, FRCP, FSCC**](/content/post/interview-with-dr-sonny-bhalla-medical-director-kinetix-medicine/index.html) Interview with Dr. Sonny Bhalla, Medical Director, Kinetix Medicine --- [**SONUS MICROSYSTEMS AND PROVIDENCE HEALTH CARE VENTURES ADVANCE PARTNERSHIP WITH NEW INVESTMENT TO ACCELERATE CLINICAL VALIDATION OF WEARABLE CARDIAC ULTRASOUND TECHNOLOGY**](/content/post/sonus-microsystems-and-providence-health-care-ventures-advance-partnership-with-new-investment-to-accelerate-clinical-validation-of-wearable-cardiac-ultrasound-technology/index.html) Investment to support clinical studies of Sonus Microsystems’s wearable ultrasound patch FOR IMMEDIATE RELEASE: October 23, 2025 VANCOUVER, British Columbia: Providence Health Care Ventures (PHCV), a strategic catalyst for health care innovation, announced today a strategic investment in Sonus Microsystems, a leader in innovative ultrasound technology, alongside angel investors including physicians in the cardiac care field. PHCV's investment marks a significant milestone. --- [**Autonomous Ultrasound: From Episodic Imaging to Continuous Patient Monitoring**](/content/post/autonomous-ultrasound/index.html) Healthcare needs imaging that behaves like a vital sign and can deliver continuous, trending, and actionable results. The goal is not just a better image at a single moment. It is better timing, earlier detection, and broader access. --- [**Sonus Microsystems and Kinetix Medicine Announce Partnership for Clinical Evaluation of Sonus’ Wearable Ultrasound Technology**](/content/post/sonus-microsystems-and-kinetix-medicine-announce-partnership-for-clinical-evaluation-of-sonus-wearable-ultrasound-technology/index.html) Sonus Microsystems, developers of an AI-powered ultrasound wearable for autonomous on-demand ultrasound, today announced the company has entered a Collaboration Agreement with Kinetix Medicine ("Kinetix"). --- [**Monitoring Vital Signs with Ultrasound**](/content/post/monitoring-vital-signs-with-ultrasound/index.html) You’ve entered an Emergency Room filled with people who, like you, are all seeking medical help. People are scattered around the ER, all...